Puma Biotechnology, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Los Angeles, CA
PBYI chart
What traders are saying about $PBYI
Latest postsPuma Biotechnology, Inc. news
- PUMA SE (PMMAF) stock price, news, quote and history
Yahoo Finance Singapore ·
- PUMA SE (PUM.DE) interactive stock chart – Yahoo Finance
Yahoo Finance Singapore ·
- Puma Biotechnology Inc Estimates – NASDAQ:PBYI
TradingView ·
- Puma Biotechnology to Host Conference Call to Discuss Third Quarter 2026 Financial Results
Yahoo Finance ·
- PBYI Q3'26 Earnings: revenue estimate is 57.50M USD
TradingView ·
- Puma Biotechnology raises 2026 guidance. Q3 results test Puma Biotechnology stock
AD HOC NEWS ·
- Will Nerlynx Continue to Aid Puma Biotechnology's Top Line in Q3?
Yahoo Finance ·
- The Zacks Analyst Blog Highlights AstraZeneca, Roche, Puma Biotechnology and Olema Oncology
Yahoo Finance ·
- 4 Breast Cancer Stocks to Watch During Breast Cancer Awareness Month
Yahoo Finance ·
- Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- PBYI's Alisertib Combo Phase II Study in Small Cell Lung Cancer Begins
Yahoo Finance ·
- Puma Biotechnology Initiates ALISCA®-Lung2, a Phase II Trial of Alisertib in Combination with Paclitaxel for the Treatment of Patients with Advanced Small Cell Lung Cancer
Yahoo Finance ·
Puma Biotechnology, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $228.4M | $230.5M | $235.6M | $228.0M |
| Net income | $31.1M | $30.3M | $21.6M | $2,000 |
| Diluted EPS | $0.61 | $0.62 | $0.45 | $0.00 |
| Total assets (year end) | $216.3M | $213.3M | $230.5M | $222.1M |
| Cash and equivalents (year end) | $29.6M | $69.2M | $84.6M | $76.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Puma Biotechnology, Inc.
- Ticker
- PBYI (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Los Angeles, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1401667
- Former names
- INNOVATIVE ACQUISITIONS CORP
Frequently asked questions
What exchange is Puma Biotechnology, Inc. listed on?
Puma Biotechnology, Inc. trades on the Nasdaq under the ticker symbol PBYI.
What industry is Puma Biotechnology, Inc. in?
Puma Biotechnology, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Puma Biotechnology, Inc. headquartered?
Puma Biotechnology, Inc.'s business address on file with the SEC is in Los Angeles, CA.
When does Puma Biotechnology, Inc.'s fiscal year end?
Puma Biotechnology, Inc.'s fiscal year ends on December 31.
How much revenue did Puma Biotechnology, Inc. report?
Puma Biotechnology, Inc. reported $228.4M in revenue for calendar year 2025, according to its SEC filings.